These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 8572582)
1. Anti-proliferative and cytokinetic effects of tumor necrosis factor-alpha, interferon-alpha and 5-fluorouracil on a human tumor xenograft. Tanaka N; Kojima K; Muro M; Naomoto Y; Moreira LF; Orita K Anticancer Res; 1995; 15(5B):1949-52. PubMed ID: 8572582 [TBL] [Abstract][Full Text] [Related]
2. Heterogeneous response of human colon cancer cells to the cytostatic and cytotoxic effects of recombinant human cytokines: interferon-alpha, interferon-gamma, tumor necrosis factor, and interleukin-1. Morikawa K; Fidler IJ J Biol Response Mod; 1989 Apr; 8(2):206-18. PubMed ID: 2499665 [TBL] [Abstract][Full Text] [Related]
3. Enhanced antitumor activity of 5-fluorouracil in combination with 2'-deoxyinosine in human colorectal cell lines and human colon tumor xenografts. Ciccolini J; Peillard L; Evrard A; Cuq P; Aubert C; Pelegrin A; Formento P; Milano G; Catalin J Clin Cancer Res; 2000 Apr; 6(4):1529-35. PubMed ID: 10778986 [TBL] [Abstract][Full Text] [Related]
4. Interferon beta increases antitumor activity of 5-fluorouracil against human colon carcinoma cells in vitro and in vivo. Kase S; Kubota T; Watanabe M; Furukawa T; Tanino H; Ishibiki K; Teramoto T; Kitajima M Anticancer Res; 1993; 13(2):369-73. PubMed ID: 8517649 [TBL] [Abstract][Full Text] [Related]
5. Combination therapy of interferon-alpha and 5-fluorouracil inhibits tumor angiogenesis in human hepatocellular carcinoma cells by regulating vascular endothelial growth factor and angiopoietins. Wada H; Nagano H; Yamamoto H; Arai I; Ota H; Nakamura M; Damdinsuren B; Noda T; Marubashi S; Miyamoto A; Takeda Y; Umeshita K; Doki Y; Dono K; Nakamori S; Sakon M; Monden M Oncol Rep; 2007 Oct; 18(4):801-9. PubMed ID: 17786339 [TBL] [Abstract][Full Text] [Related]
6. Modulation of 5-fluorouracil host-toxicity and chemotherapeutic efficacy against human colon tumors by 5-(Phenylthio)acyclouridine, a uridine phosphorylase inhibitor. Al Safarjalani ON; Rais R; Shi J; Schinazi RF; Naguib FN; el Kouni MH Cancer Chemother Pharmacol; 2006 Nov; 58(5):692-8. PubMed ID: 16528530 [TBL] [Abstract][Full Text] [Related]
7. Regrowth of 5-fluorouracil-treated human colon cancer cells is prevented by the combination of interferon gamma, indomethacin, and phenylbutyrate. Huang Y; Horvath CM; Waxman S Cancer Res; 2000 Jun; 60(12):3200-6. PubMed ID: 10866311 [TBL] [Abstract][Full Text] [Related]
8. Anti-proliferative effect of combined tumour necrosis factor-alpha and interferon-alpha on human pancreatic cancer in vitro and in vivo. Watanabe T; Fuchimoto S; Iwagaki H; Nonaka Y; Nezu M; Nishina T; Marutaka M; Susaki K; Naomoto Y; Shiki S Anticancer Res; 1993; 13(5A):1501-5. PubMed ID: 8239528 [TBL] [Abstract][Full Text] [Related]
9. Mechanisms of combined effects of gamma-interferon and 5-fluorouracil on human colon cancers implanted into nude mice. Morikawa K; Fan D; Denkins YM; Levin B; Gutterman JU; Walker SM; Fidler IJ Cancer Res; 1989 Feb; 49(4):799-805. PubMed ID: 2492206 [TBL] [Abstract][Full Text] [Related]
10. Antiproliferative effects of 5-fluorouracil and interferon-alpha in combination on a hepatocellular carcinoma cell line in vitro and in vivo. Kojiro S; Yano H; Ogasawara S; Momosaki S; Takemoto Y; Nishida N; Kojiro M J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 1):129-37. PubMed ID: 16706824 [TBL] [Abstract][Full Text] [Related]
11. Lack of antitumour activity of human recombinant tumour necrosis factor-alpha, alone or in combination with melphalan in a nude mouse human melanoma xenograft system. Furrer M; Altermatt HJ; Ris HB; Althaus U; Rüegg C; Liénard D; Lejeune FJ Melanoma Res; 1997 Aug; 7 Suppl 2():S43-9. PubMed ID: 9578416 [TBL] [Abstract][Full Text] [Related]
12. Mechanisms by which chemotherapeutic agents augment the antitumor effects of tumor necrosis factor: involvement of the pattern shift of cytokines from Th2 to Th1 in tumor lesions. Inagawa H; Nishizawa T; Honda T; Nakamoto T; Takagi K; Soma G Anticancer Res; 1998; 18(5D):3957-64. PubMed ID: 9854510 [TBL] [Abstract][Full Text] [Related]
13. Combination therapy of human pancreatic cancer implanted in nude mice by oral fluoropyrimidine anticancer agent (S-1) with interferon-alpha. Miyake K; Tsuchida K; Sugino H; Imura S; Morine Y; Fujii M; Shimada M Cancer Chemother Pharmacol; 2007 Jan; 59(1):113-26. PubMed ID: 16699793 [TBL] [Abstract][Full Text] [Related]
14. Combination of tumor necrosis factor alpha and interferon alpha induces apoptotic cell death through a c-myc-dependent pathway in p53 mutant H226br non-small-cell lung cancer cell line. Yasuoka Y; Naomoto Y; Yamatsuji T; Takaoka M; Kimura M; Uetsuka H; Matsubara N; Fujiwara T; Gunduz M; Tanaka N; Haisa M Exp Cell Res; 2001 Dec; 271(2):214-22. PubMed ID: 11716533 [TBL] [Abstract][Full Text] [Related]
15. [Synergistic effects of tumor necrosis factor interferon-gamma and chemotherapeutic drugs on human ovarian cancer cell lines in vitro]. Li J; Hui N; Zhu L Zhonghua Zhong Liu Za Zhi; 1995 Nov; 17(6):429-31. PubMed ID: 8697994 [TBL] [Abstract][Full Text] [Related]
16. Interaction of fluorouracil and interferon in human colon cancer cell lines: cytotoxic and cytokinetic effects. Wadler S; Wersto R; Weinberg V; Thompson D; Schwartz EL Cancer Res; 1990 Sep; 50(18):5735-9. PubMed ID: 1697499 [TBL] [Abstract][Full Text] [Related]
17. Suppressive effect of TNF-alpha on increased production of FdUMP by IFN-alpha. Hatano H; Tanaka N; Naomoto Y; Orita K Res Commun Mol Pathol Pharmacol; 1995 Sep; 89(3):279-90. PubMed ID: 8680797 [TBL] [Abstract][Full Text] [Related]
18. Efficacy of recombinant methioninase in combination with cisplatin on human colon tumors in nude mice. Tan Y; Sun X; Xu M; Tan X; Sasson A; Rashidi B; Han Q; Tan X; Wang X; An Z; Sun FX; Hoffman RM Clin Cancer Res; 1999 Aug; 5(8):2157-63. PubMed ID: 10473100 [TBL] [Abstract][Full Text] [Related]
19. Partial contribution of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)/TRAIL receptor pathway to antitumor effects of interferon-alpha/5-fluorouracil against Hepatocellular Carcinoma. Yamamoto T; Nagano H; Sakon M; Wada H; Eguchi H; Kondo M; Damdinsuren B; Ota H; Nakamura M; Wada H; Marubashi S; Miyamoto A; Dono K; Umeshita K; Nakamori S; Yagita H; Monden M Clin Cancer Res; 2004 Dec; 10(23):7884-95. PubMed ID: 15585621 [TBL] [Abstract][Full Text] [Related]
20. Treatment with tumor necrosis factor alpha and interferon alpha of a human kidney cancer xenograft in nude mice: evidence for an anticachectic effect of interferon alpha. Bassukas ID; Hofmockel G; Maurer-Schultze B Anticancer Res; 1994; 14(1A):237-45. PubMed ID: 8166454 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]